Dallas, TX, United States of America

John W Schoggins

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The University of Texas System. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: John W Schoggins: Innovator in Antiviral Treatments

Introduction

John W Schoggins is a prominent inventor based in Dallas, TX (US). He has made significant contributions to the field of antiviral treatments, particularly through his innovative research and patent work. His dedication to advancing medical science is evident in his groundbreaking inventions.

Latest Patents

John W Schoggins holds a patent for "Compositions and methods for treating viral infections targeting TRIM7." This patent encompasses novel antiviral compositions and methods aimed at treating viral infections. The antiviral compositions include at least one mRNA encoding for a TRIM7 protein encapsulated into a lipid nanoparticle (LNP). Additionally, the patent outlines methods for creating these antiviral compositions and administering them to subjects.

Career Highlights

Schoggins is affiliated with the University of Texas System, where he continues to engage in impactful research. His work has garnered attention for its potential to revolutionize the treatment of viral infections. With a focus on innovative solutions, he has established himself as a key figure in the field.

Collaborations

Some of his notable coworkers include Wenchun Fan and Daniel J Siegwart. Their collaborative efforts contribute to the advancement of research in antiviral therapies.

Conclusion

John W Schoggins exemplifies the spirit of innovation in the medical field through his research and patent work. His contributions to antiviral treatments highlight the importance of scientific advancement in combating viral infections.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…